Literature DB >> 22058415

Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18.

Cristina Conforti-Andreoni1, Roberto Spreafico, Hong Liang Qian, Nicolas Riteau, Bernhard Ryffel, Paola Ricciardi-Castagnoli, Alessandra Mortellaro.   

Abstract

Uric acid is released from damaged cells and serves as a danger signal that alerts the immune system to potential threats, even in the absence of microbial infection. Uric acid modulation of innate immune responses has been extensively studied, but the impact of this damage-associated molecular pattern on adaptive responses remains largely unknown. In this study, we report that, in the presence of NF-κB signaling, uric acid crystals were capable of stimulating dendritic cells to promote the release of cytokines associated with Th17 polarization. Accordingly, naive CD4(+) T cells cocultured with uric acid-treated dendritic cells differentiated toward the Th17 lineage. Th17 differentiation required the inflammasome-dependent cytokines IL-1α/β and IL-18 in both in vitro and in vivo models, and the inflammasome adaptor protein ASC and caspase-1 were essential for Th17 responses. Collectively, our findings indicate a novel role for the danger signal uric acid, in cooperation with NF-κB activation, in driving proinflammatory Th17 differentiation. Our data indicate that sterile inflammation shapes adaptive immunity, in addition to influencing early innate responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22058415     DOI: 10.4049/jimmunol.1101408

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release.

Authors:  Federica Laudisi; Roberto Spreafico; Maximilien Evrard; Timothy R Hughes; Barbara Mandriani; Matheswaran Kandasamy; B Paul Morgan; Baalasubramanian Sivasankar; Alessandra Mortellaro
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

2.  Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia.

Authors:  Vanessa R Ribeiro; Mariana Romao-Veiga; Graziela G Romagnoli; Mariana L Matias; Priscila R Nunes; Vera Therezinha M Borges; Jose C Peracoli; Maria Terezinha S Peracoli
Journal:  Immunology       Date:  2017-06-19       Impact factor: 7.397

Review 3.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

4.  Suitable Concentrations of Uric Acid Can Reduce Cell Death in Models of OGD and Cerebral Ischemia-Reperfusion Injury.

Authors:  Bin Zhang; Ning Yang; Shao-Peng Lin; Feng Zhang
Journal:  Cell Mol Neurobiol       Date:  2016-10-05       Impact factor: 5.046

Review 5.  Mechanisms of hemorrhagic cystitis.

Authors:  Subhash Haldar; Christopher Dru; Neil A Bhowmick
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

Review 6.  Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.

Authors:  Yanan Liu; Gang Zeng
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

Review 7.  At the crossroads of gout and psoriatic arthritis: "psout".

Authors:  Renaud Felten; Pierre-Marie Duret; Jacques-Eric Gottenberg; Lionel Spielmann; Laurent Messer
Journal:  Clin Rheumatol       Date:  2020-02-15       Impact factor: 2.980

Review 8.  Nonmicrobial-mediated inflammatory airway diseases--an update.

Authors:  Polani B Ramesh Babu; P Krishnamoorthy
Journal:  J Physiol Biochem       Date:  2013-11-29       Impact factor: 4.158

Review 9.  Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.

Authors:  Annayya R Aroor; Susan McKarns; Vincent G Demarco; Guanghong Jia; James R Sowers
Journal:  Metabolism       Date:  2013-08-08       Impact factor: 8.694

Review 10.  Th17 cell based vaccines in mucosal immunity.

Authors:  Pawan Kumar; Kong Chen; Jay K Kolls
Journal:  Curr Opin Immunol       Date:  2013-05-10       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.